Conway Aaron, Kennedy Wendy, Sutherland Joanna
Institute of Health and Biomedical Innovation, Queensland University Technology, Kelvin Grove, QLD, Australia.
Cardiac Catheter Laboratories, Princess Alexandra Hospital, Wooloongabba, QLD, Australia.
J Cardiothorac Vasc Anesth. 2015 Oct;29(5):1285-90. doi: 10.1053/j.jvca.2015.06.002. Epub 2015 Jun 6.
To identify the prevalence of and risk factors for inadvertent hypothermia after procedures performed with procedural sedation and analgesia in a cardiac catheterization laboratory.
A single-center, prospective observational study.
A tertiary-care private hospital in Australia.
399 patients undergoing elective procedures with procedural sedation and analgesia were included. Propofol infusions were used when an anesthesiologist was present. Otherwise, bolus doses of either midazolam or fentanyl or a combination of these medications was used.
None
Hypothermia was defined as a temperature<36.0°C. Multivariate logistic regression was used to identify risk factors. Hypothermia was present after 23.3% (n = 93; 95% confidence interval [CI] 19.2%-27.4%) of 399 procedures. Sedative regimens with the highest prevalence of hypothermia were any regimen that included propofol (n = 35; 40.2%; 95% CI 29.9%-50.5%) and the use of fentanyl combined with midazolam (n = 23; 20.3%; 95% CI 12.9%-27.7%). Difference in mean temperature from pre-procedure to post-procedure was -0.27°C (standard deviation 0.45). Receiving propofol (odds ratio [OR] 4.6 95% CI 2.5-8.6), percutaneous coronary intervention (OR 3.2; 95% CI 1.7-5.9), body mass index<25 (OR 2.5; 95% CI 1.4-4.4) and being hypothermic prior to the procedure (OR 4.9; 95% CI 2.3-10.8) were independent predictors of post-procedural hypothermia.
A moderate prevalence of hypothermia was observed. The small absolute change in temperature observed may not be a clinically important amount. More research is needed to increase confidence in the authors' estimates of hypothermia in sedated patients and its impact on clinical outcomes.
确定在心脏导管实验室进行程序性镇静镇痛操作后意外体温过低的发生率及危险因素。
单中心前瞻性观察性研究。
澳大利亚一家三级护理私立医院。
纳入399例行择期程序性镇静镇痛操作的患者。有麻醉医生在场时使用丙泊酚输注。否则,使用大剂量咪达唑仑或芬太尼或这两种药物的组合。
无
体温过低定义为体温<36.0°C。采用多因素逻辑回归分析确定危险因素。399例操作中有23.3%(n = 93;95%置信区间[CI] 19.2%-27.4%)出现体温过低。体温过低发生率最高的镇静方案是任何包含丙泊酚的方案(n = 35;40.2%;95% CI 29.9%-50.5%)以及芬太尼与咪达唑仑联合使用(n = 23;20.3%;95% CI 12.9%-27.7%)。从术前到术后平均体温差异为-0.27°C(标准差0.45)。使用丙泊酚(比值比[OR] 4.6;95% CI 2.5-8.6)、经皮冠状动脉介入治疗(OR 3.2;95% CI 1.7-5.9)、体重指数<25(OR 2.5;95% CI 1.4-4.4)以及术前体温过低(OR 4.9;95% CI 2.3-10.8)是术后体温过低的独立预测因素。
观察到体温过低的发生率中等。观察到的体温绝对变化较小,可能在临床上并不重要。需要更多研究以增强作者对镇静患者体温过低估计及其对临床结局影响的信心。